Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 60 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Ankit R.

United States

USD 60 /hr

Formulation and Bioanalytical Expert in Pharmaceutical Sciences

Profile Summary

My lab offers the development and transfer of formulations and their characterization. We do dissolution testing of the formulations as per USP guidelines. We also do rheological analysis of semisolid dosage forms. We do long and short-term stability studies for the formulations. I specialize in HPLC and LCMS-based analytical and bioanalytical studies. My work can be reviewed at: https://scholar.google.com/citations?user=_YANDjsAAAAJ&hl=en

Subject Matter Expertise

• ☆ Pharmacy
• ☆ Pharmacy Education
• ☆ Drug Development
• ☆ Drug Formulation
• ☆ Bioanalytical Testing
• ☆ Drug Stability Testing
• ☆ Preclinical ADME/PK/PD
• ☆ Bioavailability
• ☆ Pharmaceutical Manufacturing
• ☆ Pharmaceutical Process Development
• ☆ Drug Delivery Technologies
• ☆ Liposomes
• ☆ Pharmaceutical Technology

Services

• Writing
• Research
• Consulting
• Product Development

Writing Technical Writing, General Proofreading & Editing

Research Scientific and Technical Research, Secondary Data Collection

Consulting Scientific and Technical Consulting

Product Development Formulation, Recipe Development, Deformulation, Stability/Shelf Life Testing, Product Evaluation, Material Sourcing, Product Validation, Concept Development, Prototyping

Work Experience

ASSISTANT PROFESSOR

Wegmans School of Pharmacy

June 2022 - Present

Postdoctoral Fellow and Instructor

Thomas Jefferson University

April 2018 - Present

Postdoctoral Fellow

Toyo Daigaku

April 2017 - March 2018

Research and Teaching Assistant

Toyo Daigaku

April 2014 - March 2017

Senior Research Fellow

Indian Institute of Science

May 2010 - March 2014

Education

PhD in Bionanotechnology

Toyo University

March 2014 - April 2017

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

(2019). Simultaneous quantitative LC-MS method of ketamine, midazolam and their metabolites (dehydronorketamine, norketamine and 1hydroxymidazolam) for its application in patients on extracorporeal membrane oxygenation (ECMO) therapy . Journal of pharmaceutical and biomedical analysis.

(2019). Sphenopalatine Ganglion Stimulation Upregulates Transport of Intra-Arterial Temozolomide Across the Blood–Brain Barrier . Neurosurgery.

(2019). Pharmacokinetics of Ketamine at Dissociative Doses in an Adult Patient With Refractory Status Asthmaticus Receiving Extracorporeal Membrane Oxygenation Therapy . Clinical therapeutics.

(2018). Bioactive bacterial cellulose sulfate electrospun nanofibers for tissue engineering applications . Journal of tissue engineering and regenerative medicine.

(2018). Formulation, characterization and evaluation of morusin loaded niosomes for potentiation of anticancer therapy . RSC Advances.

(2017). Smart Carriers and Nanohealers: A Nanomedical Insight on Natural Polymers . Materials (Basel, Switzerland).

(2017). Poly-lactic-co-glycolic acid Nanoformulation of Small Molecule Antagonist GANT61 for Cancer Annihilation by Modulating Hedgehog Pathway . NanoWorld Journal.

(2016). Dual mode of cancer cell destruction for pancreatic cancer therapy using Hsp90 inhibitor loaded polymeric nano magnetic formulation . International journal of pharmaceutics.

(2015). Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development . Antimicrobial agents and chemotherapy.

(2015). Heat-Shock Protein 90-Targeted Nano Anticancer Therapy . Journal of pharmaceutical sciences.

(2014). Heat shock protein 90 as a potential drug target against surra . Parasitology.

(2013). Heat shock protein 90 inhibitors as broad spectrum anti-infectives . Current pharmaceutical design.

(2011). Clinical proteomics of the neglected human malarial parasite Plasmodium vivax . PloS one.

BOOK CHAPTER

(2013). CHAPTER 14. Heat-shock Protein 90 as an Antimalarial Target . Drug Discovery.